1.1 Articolo in rivista

1.1 Articolo in rivista: [31196] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 10.901 a 10.920 di 31.196

Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men” AIDS

2003-01-01 Lo Caputo, S; Trabattoni, ; Daria, ; Vichi, ; Francesca, ; Piconi, ; Stefania, ; Lopalco, ; Lucia, ; Villa, ; Maria, Luisa; Mazzotta, ; Francesco, ; Clerici, ; Mario,

Resistance to Dideoxynucleoside Reverse Transcriptase Inhibitors: Genotypic-Phenotypic Correlations

2004-01-01 Torti, ; Carlo, ; Quiros-Roldan, ; Eugenia, ; Monno, ; Laura, ; Patroni, ; Andrea, ; Saracino, ; Annalisa, ; Angarano, ; Gioacchino, ; Tinelli, ; Carmine, ; Lo Caputo, S; Pierotti, ; Piera, ; Mazzotta, ; Francesco, ; Carosi, ; Giampiero, ; for the, Genpherex; PhenGen Study Groups of the MASTER Cohort, HIV-1

A common polymorphism in TLR3 confers natural resistance to HIV-1 infection

2012-01-01 Sironi, M; Biasin, M; Cagliani, R; Forni, D; De Luca, M; Saulle, I; Lo Caputo, S; Mazzotta, F; Macías, J; Pineda, Ja; Caruz, A; Clerici, M

HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy

2005-01-01 Laura, Monno; Gaetano, Brindicci; Lo Caputo, S; Grazia, Punzi; Teresa, Scarabaggio; Chiara, Riva; Cesare Di, Bari; Piera, Pierotti; Annalisa, Saracino; Antonella, Lagioia; Francesco, Mazzotta; Claudia, Balotta; Gioacchino, Angarano

Endoplasmic reticulum aminopeptidase 2 haplotypes ply a role in modulating susceptibility to HIV infection

2013-01-01 Biasin, M; Sironi, M; Saulle, I; de Luca, M; la Rosa, F; Cagliani, R; Forni, D; Agliardi, C; Lo Caputo, S; Mazzotta, F; Trabattoni, D; Macias, J; Pineda, Ja; Caruz, A; Clerici, M

Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

2014-01-01 Lichtner, M; Cicconi, P; Vita, S; Cozzi-Lepri, A; Galli, M; Lo Caputo, S; Saracino, A; De Luca, A; Moioli, M; Maggiolo, F; Marchetti, G; Vullo, V; d'Arminio Monforte, A; for the ICONA Foundation, Study

Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission

1993-01-01 Fiore, ; José, R.; Jansson, ; Marianne, ; Scarlatti, ; Gabriella, ; Angarano, ; Gioacchino, ; Lo Caputo, S; Buccoliero, ; Giovanni, ; Rossi, ; Paolo, ; Fenyö, ; Eva, Maria; Pastore, ; Giuseppe,

The elderly and direct antiviral agents: Constraint or challenge?

2017-01-01 Fabrizio, C; Saracino, A; Scudeller, L; Milano, E; Dell'Acqua, R; Bruno, G; Lo Caputo, S; Monno, L; Milella, M; Angarano, G.

PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection

2017-01-01 Di Biagio, A; Riccardi, N; Signori, A; Maserati, R; Nozza, S; Gori, A; Bonora, S; Borderi, M; Ripamonti, D; Rossi, Mc; Orofino, G; Quirino, T; Nunnari, G; Celesia, Bm; Martini, S; Sagnelli, C; Mazzola, G; Colletti, P; Bartolozzi, D; Bini, T; Ladisa, N; Castelnuovo, F; Saracino, A; Lo Caputo, S

HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations

2003-01-01 Luigia, Scudeller; Carlo, Torti; Eugenia, Quiros-Roldan; Andrea, Patroni; Lo Caputo, S; Francesca, Moretti; Francesco, Mazzotta; Elisa, Donati; Angela, Vivarelli; and Giampiero Carosi on behalf of the GenPheRex Group of the MASTER, Cohort

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

2012-01-01 Armenia, D; Vandenbroucke, I; Fabeni, L; Van Marck, H; Cento, V; D'Arrigo, R; Van Wesenbeeck, L; Scopelliti, F; Micheli, V; Bruzzone, B; Lo Caputo, S; Aerssens, J; Rizzardini, G; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf; Ceccherini-Silberstein, F

Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection

2010-01-01 Cagliani, R; Riva, S; Biasin, M; Fumagalli, M; Pozzoli, U; Lo Caputo, S; Mazzotta, F; Piacentini, L; Bresolin, N; Clerici, M; Sironi, M

Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy

2009-01-01 A., Antinori; A., Ammassari; C., Torti; P., Marconi; M., Andreoni; G., Angarano; S., Bonora; A., Castagna; R., Cauda; M., Clerici; A., d’Arminio Monforte; A., De Luca; G., Di Perri; M., Galli; E., Girardi; A., Gori; A., Lazzarin; Lo Caputo, S; F., Mazzotta; F., Montella; C., Mussini; Perno, C. F.; M., Puoti; G., Rizzardini; S., Rusconi; V. Vullo and G., Carosi

Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection

2015-01-01 Herrero, R; Real, Lm; Rivero-Juárez, A; Pineda, Ja; Camacho, Á; Macías, J; Laplana, M; Konieczny, P; Márquez, Fj; Souto, Jc; Soria, Jm; Saulle, I; Lo Caputo, S; Biasin, M; Rivero, A; Fibla, J; Caruz, A

96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience

2012-01-01 Capetti, A; Landonio, S; Meraviglia, P; Di Biagio, A; Lo Caputo, S; Sterrantino, G; Ammassari, A; Menzaghi, B; Franzetti, M; De Socio, Gv; Pellicanò, G; Mazzotta, E; Soria, A; Meschiari, M; Trezzi, M; Sasset, L; Celesia, Bm; Zucchi, P; Melzi, S; Ricci, E; Rizzardini, G

Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study

2014-01-01 Capetti, A; Meraviglia, P; Landonio, S; Sterrantino, G; Di Biagio, A; Lo Caputo, S; Ammassari, A; Menzaghi, B; De Socio, Gv; Franzetti, M; Soria, A; Meschiari, M; Sasset, L; Pellicanò, G; Mazzotta, E; Trezzi, M; Celesia, Bm; Melzi, S; Carenzi, L; Ricci, E; Rizzardini, G

Toll-like receptor activation pathways in HIV-1 exposed seronegative individuals

2010-01-01 Mara, Biasin*; Luca, Piacentini*; Lo Caputo, S; Valentina, Naddeo*; Piera, Pierotti†; Manuela, Borelli*; Daria, Trabattoni*; Francesco, Mazzotta†; Gene M., Shearer‡; Mario, Clerici

Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals

2016-01-01 Yahyaei, S; Biasin, M; Saulle, I; Gnudi, F; De Luca, M; Tasca, Ki; Trabattoni, D; Lo Caputo, S; Mazzotta, F; Clerici, M

First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006)

2007-01-01 G., Carosi; E., Quiros-Roldan; C., Torti; A., Antinori; M., Bevilacqua; R. C., Bonadonna; P., Bonfanti; A., Castagna; R., Cauda; A., d’Arminio-Monforte; P., Di Gregorio; G., Di Perri; R., Esposito; F., Fatuzzo; C., Gervasoni; C., Giannattasio; G., Guaraldi; A., Lazzarin; Lo Caputo, S; P., Maggi; F., Mazzotta; M., Moroni; T., Prestileo; R., Ranieri; G., Rizzardini; R., Russo; M., Galli and members of the Italian Cardiovascular Risk Guidelines Working Group

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort

2017-01-01 d'Arminio Monforte, A; Cozzi-Lepri, A; Ceccherini-Silberstein, F; De Luca, A; Lo Caputo, S; Castagna, A; Mussini, C; Cingolani, A; Tavelli, A; Shanyinde, M; Gori, A; Girardi, E; Andreoni, M; Antinori, A; Puoti, M; Icona Foundation and HepaIcona Study, Group

Titolo	Data di pubblicazione	Autore(i)
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men” AIDS	1-gen-2003	Lo Caputo, S; Trabattoni, ; Daria, ; Vichi, ; Francesca, ; Piconi, ; Stefania, ; Lopalco, ; Lucia, ; Villa, ; Maria, Luisa; Mazzotta, ; Francesco, ; Clerici, ; Mario,
Resistance to Dideoxynucleoside Reverse Transcriptase Inhibitors: Genotypic-Phenotypic Correlations	1-gen-2004	Torti, ; Carlo, ; Quiros-Roldan, ; Eugenia, ; Monno, ; Laura, ; Patroni, ; Andrea, ; Saracino, ; Annalisa, ; Angarano, ; Gioacchino, ; Tinelli, ; Carmine, ; Lo Caputo, S; Pierotti, ; Piera, ; Mazzotta, ; Francesco, ; Carosi, ; Giampiero, ; for the, Genpherex; PhenGen Study Groups of the MASTER Cohort, HIV-1
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection	1-gen-2012	Sironi, M; Biasin, M; Cagliani, R; Forni, D; De Luca, M; Saulle, I; Lo Caputo, S; Mazzotta, F; Macías, J; Pineda, Ja; Caruz, A; Clerici, M
HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy	1-gen-2005	Laura, Monno; Gaetano, Brindicci; Lo Caputo, S; Grazia, Punzi; Teresa, Scarabaggio; Chiara, Riva; Cesare Di, Bari; Piera, Pierotti; Annalisa, Saracino; Antonella, Lagioia; Francesco, Mazzotta; Claudia, Balotta; Gioacchino, Angarano
Endoplasmic reticulum aminopeptidase 2 haplotypes ply a role in modulating susceptibility to HIV infection	1-gen-2013	Biasin, M; Sironi, M; Saulle, I; de Luca, M; la Rosa, F; Cagliani, R; Forni, D; Agliardi, C; Lo Caputo, S; Mazzotta, F; Trabattoni, D; Macias, J; Pineda, Ja; Caruz, A; Clerici, M
Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients	1-gen-2014	Lichtner, M; Cicconi, P; Vita, S; Cozzi-Lepri, A; Galli, M; Lo Caputo, S; Saracino, A; De Luca, A; Moioli, M; Maggiolo, F; Marchetti, G; Vullo, V; d'Arminio Monforte, A; for the ICONA Foundation, Study
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission	1-gen-1993	Fiore, ; José, R.; Jansson, ; Marianne, ; Scarlatti, ; Gabriella, ; Angarano, ; Gioacchino, ; Lo Caputo, S; Buccoliero, ; Giovanni, ; Rossi, ; Paolo, ; Fenyö, ; Eva, Maria; Pastore, ; Giuseppe,
The elderly and direct antiviral agents: Constraint or challenge?	1-gen-2017	Fabrizio, C; Saracino, A; Scudeller, L; Milano, E; Dell'Acqua, R; Bruno, G; Lo Caputo, S; Monno, L; Milella, M; Angarano, G.
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection	1-gen-2017	Di Biagio, A; Riccardi, N; Signori, A; Maserati, R; Nozza, S; Gori, A; Bonora, S; Borderi, M; Ripamonti, D; Rossi, Mc; Orofino, G; Quirino, T; Nunnari, G; Celesia, Bm; Martini, S; Sagnelli, C; Mazzola, G; Colletti, P; Bartolozzi, D; Bini, T; Ladisa, N; Castelnuovo, F; Saracino, A; Lo Caputo, S
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations	1-gen-2003	Luigia, Scudeller; Carlo, Torti; Eugenia, Quiros-Roldan; Andrea, Patroni; Lo Caputo, S; Francesca, Moretti; Francesco, Mazzotta; Elisa, Donati; Angela, Vivarelli; and Giampiero Carosi on behalf of the GenPheRex Group of the MASTER, Cohort
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing	1-gen-2012	Armenia, D; Vandenbroucke, I; Fabeni, L; Van Marck, H; Cento, V; D'Arrigo, R; Van Wesenbeeck, L; Scopelliti, F; Micheli, V; Bruzzone, B; Lo Caputo, S; Aerssens, J; Rizzardini, G; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf; Ceccherini-Silberstein, F
Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection	1-gen-2010	Cagliani, R; Riva, S; Biasin, M; Fumagalli, M; Pozzoli, U; Lo Caputo, S; Mazzotta, F; Piacentini, L; Bresolin, N; Clerici, M; Sironi, M
Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy	1-gen-2009	A., Antinori; A., Ammassari; C., Torti; P., Marconi; M., Andreoni; G., Angarano; S., Bonora; A., Castagna; R., Cauda; M., Clerici; A., d’Arminio Monforte; A., De Luca; G., Di Perri; M., Galli; E., Girardi; A., Gori; A., Lazzarin; Lo Caputo, S; F., Mazzotta; F., Montella; C., Mussini; Perno, C. F.; M., Puoti; G., Rizzardini; S., Rusconi; V. Vullo and G., Carosi
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection	1-gen-2015	Herrero, R; Real, Lm; Rivero-Juárez, A; Pineda, Ja; Camacho, Á; Macías, J; Laplana, M; Konieczny, P; Márquez, Fj; Souto, Jc; Soria, Jm; Saulle, I; Lo Caputo, S; Biasin, M; Rivero, A; Fibla, J; Caruz, A
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience	1-gen-2012	Capetti, A; Landonio, S; Meraviglia, P; Di Biagio, A; Lo Caputo, S; Sterrantino, G; Ammassari, A; Menzaghi, B; Franzetti, M; De Socio, Gv; Pellicanò, G; Mazzotta, E; Soria, A; Meschiari, M; Trezzi, M; Sasset, L; Celesia, Bm; Zucchi, P; Melzi, S; Ricci, E; Rizzardini, G
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study	1-gen-2014	Capetti, A; Meraviglia, P; Landonio, S; Sterrantino, G; Di Biagio, A; Lo Caputo, S; Ammassari, A; Menzaghi, B; De Socio, Gv; Franzetti, M; Soria, A; Meschiari, M; Sasset, L; Pellicanò, G; Mazzotta, E; Trezzi, M; Celesia, Bm; Melzi, S; Carenzi, L; Ricci, E; Rizzardini, G
Toll-like receptor activation pathways in HIV-1 exposed seronegative individuals	1-gen-2010	Mara, Biasin; Luca, Piacentini; Lo Caputo, S; Valentina, Naddeo; Piera, Pierotti†; Manuela, Borelli; Daria, Trabattoni; Francesco, Mazzotta†; Gene M., Shearer‡; Mario, Clerici*
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals	1-gen-2016	Yahyaei, S; Biasin, M; Saulle, I; Gnudi, F; De Luca, M; Tasca, Ki; Trabattoni, D; Lo Caputo, S; Mazzotta, F; Clerici, M
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006)	1-gen-2007	G., Carosi; E., Quiros-Roldan; C., Torti; A., Antinori; M., Bevilacqua; R. C., Bonadonna; P., Bonfanti; A., Castagna; R., Cauda; A., d’Arminio-Monforte; P., Di Gregorio; G., Di Perri; R., Esposito; F., Fatuzzo; C., Gervasoni; C., Giannattasio; G., Guaraldi; A., Lazzarin; Lo Caputo, S; P., Maggi; F., Mazzotta; M., Moroni; T., Prestileo; R., Ranieri; G., Rizzardini; R., Russo; M., Galli and members of the Italian Cardiovascular Risk Guidelines Working Group
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort	1-gen-2017	d'Arminio Monforte, A; Cozzi-Lepri, A; Ceccherini-Silberstein, F; De Luca, A; Lo Caputo, S; Castagna, A; Mussini, C; Cingolani, A; Tavelli, A; Shanyinde, M; Gori, A; Girardi, E; Andreoni, M; Antinori, A; Puoti, M; Icona Foundation and HepaIcona Study, Group

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 10.901 a 10.920 di 31.196

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext30726
open363
restricted77
reserved29
partially open1